The correlation between serum asprosin and type 2 diabetic patients with obesity in the community
Serum asprosin was correlated with obesity in community-based type 2 diabetic patients with obesity. Additionally, the risk of obesity was obviously increased with the raise of asprosin. Therefore, we speculate that serum asprosin could be used as a risk predictor of type 2 diabetic patients with obesity.
Authors
- Xiaoyu Li
- Lijing Ma (ORCID: https://orcid.org/0000-0003-2707-0677)
- Liang Dong (ORCID: https://orcid.org/0000-0003-1782-6848)
- Jing Yang (ORCID: https://orcid.org/0000-0002-9397-313X)
- Chen-Yu Xiang
- Yan Wang (ORCID: https://orcid.org/0000-0002-6018-3545)
- Yi Ren (ORCID: https://orcid.org/0000-0001-6004-4636)
- Minggang Xu
- Fen Zheng
- Linxin Xu
Institutions
- Shanxi Medical University (CN)
- First Hospital of Shanxi Medical University (CN)
- Hypertension Institute (US)
- Xian Yang Central Hospital (CN)
Publication Details
- Journal
- Frontiers in Endocrinology
- Published
- 2025-05-05
- DOI
- https://doi.org/10.3389/fendo.2025.1535668
- Citations
- 5
- Primary Topic
- Adipokines, Inflammation, and Metabolic Diseases
- Type
- article
- Field-Weighted Citation Impact
- 6.77
Funders
- Natural Science Foundation of Shanxi Province